Literature DB >> 12528365

Application of G-proteins in the molecular diagnosis of psychiatric disorders.

Gabriel Schreiber1, Sofia Avissar.   

Abstract

Mental disorders are highly prevalent and often difficult to diagnose. Although significant advances have been achieved in medication for mental disorders, the diagnosis and treatment monitoring of these disorders remain in a static situation. The absence of objective diagnostic 'gold standards', derives from the special complexity of diagnosis in psychiatry. Heterotrimeric G-proteins are crucial elements in post-receptor information transduction. These proteins have been implicated in the biochemical mechanism of action of drugs used to treat psychiatric disorders. G-protein measurements have unravelled a differential pattern characteristic of each of the major mental disorders. The accumulated data supports the potential use of G-protein measures as state-dependent markers for the biochemical diagnosis of mental disorders and as aid in the biochemical monitoring of the response to a specific treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12528365     DOI: 10.1586/14737159.3.1.69

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN: 1473-7159            Impact factor:   5.225


  4 in total

1.  Phenylthiocarbamide (PTC) perception in patients with schizophrenia and first-degree family members: relationship to clinical symptomatology and psychophysical olfactory performance.

Authors:  Paul J Moberg; Colleen McGue; Stephen J Kanes; David R Roalf; Catherine C Balderston; Raquel E Gur; Christian G Kohler; Bruce I Turetsky
Journal:  Schizophr Res       Date:  2007-01-08       Impact factor: 4.939

2.  Deficiency of the purine metabolic gene HPRT dysregulates microRNA-17 family cluster and guanine-based cellular functions: a role for EPAC in Lesch-Nyhan syndrome.

Authors:  Ghiabe-Henri Guibinga; Fiona Murray; Nikki Barron; William Pandori; Gorjan Hrustanovic
Journal:  Hum Mol Genet       Date:  2013-06-25       Impact factor: 6.150

3.  Evidence for alterations in stimulatory G proteins and oxytocin levels in children with autism.

Authors:  Jill D Jacobson; Kathryn A Ellerbeck; Kelsie A Kelly; Kandace K Fleming; T Rene Jamison; Charles W Coffey; Catherine M Smith; R Matthew Reese; Scott A Sands
Journal:  Psychoneuroendocrinology       Date:  2013-11-26       Impact factor: 4.905

4.  Beta-Arrestin1 Levels in Mononuclear Leukocytes Support Depression Scores for Women with Premenstrual Dysphoric Disorder.

Authors:  Farzana Alam; Sanket Nayyar; William Richie; Anthony Archibong; Tultul Nayyar
Journal:  Int J Environ Res Public Health       Date:  2015-12-22       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.